Regina Barzilay
Consultant / Advisor chez JOHNSON & JOHNSON
Profil
Regina Barzilay is currently the Director at Dewpoint Therapeutics, Inc. and a member of the Scientific Advisory Board at Johnson & Johnson.
She is also a Venture Partner at Catalio Capital Management LP.
Barzilay holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Ben-Gurion University of the Negev.
Postes actifs de Regina Barzilay
| Sociétés | Poste | Début |
|---|---|---|
| JOHNSON & JOHNSON | Consultant / Advisor | 01/01/2018 |
Dewpoint Therapeutics, Inc.
 Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Directeur/Membre du Conseil | 16/02/2021 |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Formation de Regina Barzilay
| Ben-Gurion University of the Negev | Undergraduate Degree |
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Entreprise privées | 2 |
|---|---|
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Health Technology |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
